DIGITAL RHEUMATOLOGY
Our platform delivers optimized,
AI-powered expert care
to patients living with chronic rheumatological diseases.
For patients
AppliGoutte, the first therapeutic support app for treating gout
AppliGoutte is a mobile app for people living with gout, currently available in French. It provides unique daily support: a therapeutic education program covering the disease and its treatments, help with pre-diagnosis and flare management, and monitoring of the recovery pathway alongside background treatment.
It is prescribed or recommended by our partner healthcare professionals and is also available to all patients, as a support to their medical care.
For healthcare professionals
Optimize the care pathway with our expert algorithms and remote monitoring
As rheumatologists become increasingly scarce and face growing numbers of chronic, multi-condition patients, our platform makes expert monitoring of active patient panels easier, in both outpatient and hospital settings.
Developed by international gout experts, our current solution enables state-of-the-art remote management of gout patients through our AppliGoutte patient app, which transmits all the data the platform needs.
Scientific framework
Clinical Research
Our solutions are developed within a rigorous scientific framework, drawing on the latest international knowledge and recommendations. They are implemented to support state-of-the-art care, and we demonstrate their clinical effectiveness through studies conducted on our various solutions, in outpatient and hospital settings. Our goal is also to generate new knowledge about these diseases, in particular novel predictive models.
Our partners
Latest news
News
Our fundraising round continues through September. If you would like access to the deck, it is here 👉 https://rebrand.ly/rheuma-care
Rheuma Care is entering the final stretch of its fundraising round.
To introduce you to the company and team, and answer your questions live, join us on Wednesday, September 17 at 12:00 PM (Paris time).
This will be an opportunity to go over Rheuma Care’s business model, our clinical, regulatory and technology roadmap, and the terms of the round.
The registration link will be shared soon.
Come and meet us at the French Society of Rheumatology (SFR) congress, December 13–15, 2026, at the Palais des Congrès, Porte de Versailles.
Company
About us
- Provide every person living with a chronic rheumatic disease the expert care they deserve
- Fight the missed opportunities that have a broad impact on life (disability, sick leave, hospitalizations)
- Prevent frailty: comorbidities and increased risk of morbidity and mortality
- Break down prejudice and misconceptions about certain diseases, such as gout
In 2019, Prof. Hang-Korng Ea, from the expert gout unit at Lariboisière Hospital in Paris, decided to develop a mobile app to improve treatment adherence for people with gout, letting them track their progress along their care pathway. With the involvement of Sharon Abiven, then a PhD intern, and Perrine Courtois, who led the design-centered methodology, development and project management, a first prototype emerged. It draws in particular on a specific psycho-behavioral model based on the HAPA model (Health Action Process Approach, developed by Prof. Ralf Schwarzer).
In 2023, Rheuma Care SAS was founded to develop and commercialize a first complete gout-focused solution, including an advanced version of the mobile app that can be prescribed by healthcare professionals alongside drug treatment, and a remote monitoring platform.
Leadership team
- CEO: Perrine Courtois
- CTO: Prasanth Pushparasah
- CSO: Prof. Hang-Korng Ea
- CMO: Dr. Sharon Abiven Delattre
- Guy Eiferman: Former President of MSD France and founder of Merck & Co.’s digital health division, he brings international strategic vision and expertise in business development.
- Hubert Méchin: Physician and entrepreneur, former executive at Docaposte Santé and former President of the French Association of Clinical Research Companies (AFCROs), he brings expertise in clinical trials, health data, artificial intelligence and digital health.
- Régis Sénégou: Former CEO of Cegedim Logiciels Médicaux and Sephira, co-founder of Moovcare, and former executive at Docaposte Santé, he is a committed player in e-health and digital health policy in France.
- BPI France
- France 2030 – Caisse des Dépôts et Consignations
- Wilco
RHEUMACARE — Digital Rheumatology
© 2026 RHEUMACARE. All rights reserved.